Forecasting the Future of a Changing Field
Join us for the 12th year of the most comprehensive event on Compound & Sample Management in the US!
Drive scientific advancement through efficient management of your vast, diverse, and ever-changing compound libraries and biobanks.
As our investigators fine tune their skills in identifying new assays that can lead to the emergence of breakthrough medicines, they must be able to swiftly access and use the compounds needed for development. Lapses in supply, compromised quality, and siloed data all lead to delays in new drugs getting to the patients’ who need them. Through empowering a cross-functional, global team to effectively manage lab operations from sample management to data integrity to advanced automation, the drug discovery process will reach new heights.
We have expanded our focus in 2016 to address the most pressing topics in compound AND biological sample management. While the two sides often share challenges, it is important to recognize key synergies and differences in order to take the most proactive management approach.
CEO & President
Scigilian Software Inc.
Scigilian Software Inc
Global Lead, Discovery Bioassets
Assistant Professor, Dept. of Molecular Therapeutics, Lead-ID, Director of
The Scripps Research Institute, Florida
Genomics Institute of the Novartis Research Foundation
Research Scientist, Center for Applied Genomics
The Children`s Hospital of Philadelphia
Director of High Throughput Screening
Vanderbilt Institute of Chemical Biology
Manager; Logistics, Data Management
Compound Management Supervisor
St. Jude Children`s Research Hospital
US Department of Veteran Affairs
Project Coordinator, Developmental Biology & Solid Tumor Program
St. Jude Children's Research Hospital
Associate Director Research
Merck & Co
Regional Hazard Communication Coordinator for OSHA Region 3
Director, Center for Applied Genomics
Childrens Hospital Of Philadelphia
Discovery Supply- Global Biological Assets
Director, Lead Discovery & Optimization
Regional Compliance Assistance Specialist for Region 3
Vice President of Sample Management Technologies
Senior Scientist, Research
Director, Discovery Sample Management
Director of Operations
St. Jude Children's Research Hospital
Compound Management Team Leader
Principal Research Associate in Lead Discovery
What will you learn in 2016?
Efficiently track compounds & bio samples throughout your collection to ensure quality and allow for strategic additions
Manage the volume and complexity of data collected through high-throughput screening
Integrate your IT and equipment for an enhanced informatics infrastructure that further supports lab operations
Discuss trends in lab automation and robotics that are changing the landscape of drug discovery
Explore the direct impact of compound & sample management on lead discovery through to clinical trials
Review the benefits of taking a phenotypic screening approach over traditional methods
Streamline your CRO communication through stringent site checks of their compound management processes
Adopt a “do more with less” mentality to optimize your sample usage and minimize waste
Master the detailed international shipping regulations for transporting both compound and biological samples across borders
Collaborate with partners both corporate and academic to further innovation in drug discovery
“It has been incredibly pleasant to see other companies experiencing the same hardships and challenges as our company"
“Very worthwhile to get a sense of other peoples sample handling operations.”
“The conference provided a great format for checking in with industry peers on their challenges in compound management. The exchange of ideas stimulated lively discussions, with practical approaches to solving problems in workflows, hardware/software/facilities infrastructure, and the timely meeting of business deliverables.”
“There was a strong collaborative environment.”
“Great networking event with some exceptional presentations and panels.”
Event Calendar 2016 - Pharma, Cold Chain, and Healthcare Portfolio
We've put together this document to give you an idea of our Pharma summits, which are slated to run in 2016. Which are you attending?